Press release
Active Pharmaceutical Ingredient Market Predicted to Reach US$ 307.5 Billion at a CAGR of 4% by 2034
Active Pharmaceutical Ingredient Market
The market serves as a fundamental cornerstone of the pharmaceutical sector, playing a crucial role in delivering the therapeutic effects of medications. Active pharmaceutical ingredients (APIs) represent bioactive compounds that impart the necessary pharmacological actions to drugs, enabling their efficacy in addressing diverse medical conditions.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9124
The global active pharmaceutical ingredient (API) market is experiencing significant growth, driven by various factors such as the increasing prevalence of chronic diseases, rising demand for generic drugs, advancements in drug development technologies, and the growing focus on personalized medicine.
Growing Demand for Generic Drugs:
One of the primary drivers of the API market's growth is the increasing demand for generic drugs. As patents for several branded drugs expire, pharmaceutical companies are focusing on developing generic versions of these drugs to cater to the growing demand for affordable healthcare solutions. APIs serve as the key ingredients in generic drugs, and their availability and cost-effectiveness play a crucial role in driving market growth.
Shift Towards Outsourcing:
Pharmaceutical companies are increasingly outsourcing the manufacturing of APIs to specialized contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs). Outsourcing allows companies to benefit from cost savings, access specialized expertise, and streamline their operations. Additionally, outsourcing enables companies to focus on their core competencies such as drug discovery and commercialization while leveraging the capabilities of external partners for API manufacturing.
Increasing Focus on Biologics:
Biological drugs, including monoclonal antibodies, peptides, and recombinant proteins, represent a growing segment of the pharmaceutical market. APIs for biologics are produced using complex biotechnological processes and require specialized manufacturing facilities. As the demand for biologics continues to rise, there is a growing emphasis on the development and manufacturing of biologically derived APIs. This trend presents opportunities for companies specializing in biopharmaceutical manufacturing and biotechnology.
Regulatory Compliance and Quality Assurance:
Stringent regulatory requirements and quality standards govern the manufacturing and distribution of APIs to ensure patient safety and product efficacy. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) impose strict guidelines for API manufacturing practices, including good manufacturing practices (GMP) and quality control measures. Compliance with these regulations is essential for API manufacturers to obtain regulatory approvals and maintain market credibility.
๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
Bristol-Myers Squibb Company
Pfizer Inc.
Boehringer Ingelheim
Cipla Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline PLC
Hepalink Group
Merck & Co. Inc.
Sandoz International GmbH
Aurobindo Pharma Limited
Fresenius Kabi LLC
Teva Pharmaceutical Industries Ltd.
Sanofi
Novartis AG
Mylan N.V.
AbbVie, Inc.
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐:
The active pharmaceutical ingredient (API) market's competitive landscape is a dynamic mix of established pharmaceutical titans, contract manufacturing organizations (CMOs), and emerging entities vying for market dominance through innovation, strategic partnerships, and global expansions.
Pfizer Inc. reaffirmed its commitment to US manufacturing in June 2022 by injecting US$ 120 million into its Kalamazoo, Michigan facility. This investment will facilitate domestic production of its COVID-19 oral medication, PAXLOVIDTM (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), boosting API and registered starting materials (RSMs) output for nirmatrelvir. The move is anticipated to create over 250 new high-skilled jobs at Pfizer's Kalamazoo site.
Meanwhile, Teva Pharmaceuticals is channeling investments into biologics production technology for APIs with cells aimed at biosimilars and novel biologics. This strategic move aligns with the escalating demand for biopharmaceutical products, positioning Teva Pharmaceuticals to capitalize on emerging market opportunities and solidify its market presence.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐จ๐ ๐๐๐ญ๐ข๐ฏ๐ ๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐ง๐ ๐ซ๐๐๐ข๐๐ง๐ญ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก
By API Type :
Small Molecules
Peptides & Oligonucleotides
Carbohydrate Drugs
Steroidal Drugs
Others
By Synthesis Type :
Biotech
Synthetic
By Manufacturer Type :
Captive APIs
Merchant APIs
By End User :
Pharmaceutical Companies
Biopharmaceutical Companies
CMOs
CDMOs
By Region :
North America
Latin America
Europe
East Asia
South Asia & Oceania
Middle East & Africa
The global API market is witnessing significant growth driven by factors such as the increasing demand for generic drugs, outsourcing trends, the rise of biologics, regulatory compliance requirements, and technological advancements. As pharmaceutical companies continue to innovate and adapt to evolving market dynamics, the API sector is expected to play a pivotal role in shaping the future of the pharmaceutical industry.
๐๐จ๐ฉ ๐๐๐ฅ๐๐ญ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ง ๐ญ๐ก๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ
Sterile Active Pharmaceutical Ingredient Market
https://www.factmr.com/report/1702/sterile-active-pharmaceutical-ingredient-market
Monoclonal Antibodies Market
https://www.factmr.com/report/monoclonal-antibodies-market
Lipids Active Pharmaceutical Ingredient Market
https://www.factmr.com/report/962/lipids-active-pharmaceutical-ingredient-market
๐๐จ๐ง๐ญ๐๐๐ญ:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
๐๐๐จ๐ฎ๐ญ ๐ ๐๐๐ญ.๐๐
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Active Pharmaceutical Ingredient Market Predicted to Reach US$ 307.5 Billion at a CAGR of 4% by 2034 here
News-ID: 3390261 • Views: โฆ
More Releases from Fact.MR
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decodingโฆ
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke โฆ
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleanersโฆ
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offeringโฆ
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 โฆ
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhanceโฆ
More Releases for API
Api 607 Vs API 608: A Comprehensive Comparison Guide Of Industrial Valve
Introduction: Why are API standards so important for industrial valves?
In high-risk industries such as oil and gas, chemicals and power, the safety and reliability of valves can directly affect the stability of production systems. The standards set by API (American Petroleum Institute) are the technical bible of industrial valves around the world. Among them, API 607 and API 608 are key specifications frequently cited by engineers and buyers.
This article willโฆ
Vehicle API Market 2023 | Futuristic Technology- CarAPI, Caruso, One Auto API, A โฆ
The Vehicle API market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Vehicle API report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period.
The Vehicle API research report also provides insights of different regions that areโฆ
Face Recognition API Market Growth, Business Overview 2023, and Forecast to 2030 โฆ
Facial recognition is a way of recognizing a human face through technology. A facial detection system uses biometrics to map facial features from a photograph or video. It compares information with a database of known faces to find a match. Moreover, the accuracy of facial recognition systems has improved way better in the last decade. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger,โฆ
API Management Market Report 2018: Segmentation by Solution (API Portal, API Gat โฆ
Global API Management market research report provides company profile for Akana, Inc. (U.S.), Apiary, Inc. (U.S.), Axway, Inc. (France), CA Technologies, Inc. (U.S.), Cloud Elements, Inc. (U.S.), Dell Boomi, Inc. (U.S.), DigitalML (U.S.), Fiorano Software, Inc. (U.S.), Google, Inc. (U.S.), Hewlett-Packard Enterprises Co. (U.S.), IBM Corporation (U.S.), Mashape Inc. (U.S.) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historicalโฆ
Telecom API Market: OTT Service Providers Continue Cutting into Telecom API Prof โฆ
The highly fragmented market of telecom API holds a staggering number of service providers and aggregators that are already offering their APIs to various telecom carriers. Alcatel Lucent, Apigee Corp., and Fortumo OU were the leading providers of telecom API from a global perspective in 2014. Telecom carriers have partnered with them and other prominent players in the past to launch APIs in the market.
According to Transparency Market Researchโs latestโฆ
Small Molecule API Market Growth Drivers 2018 | by Types Synthetic/Chemical API, โฆ
Complete Study of Small Molecule API Market Research Report is added on MarketResearchFuture.com with Latest Advancement. Detail analysis on possible segments and sub segments of the Small Molecule API Market. Along with this regional analysis of the market which includes North America, Europe, Asia Pacific and Middle East and Africa.
Global Small Molecule API Market โ Overview
Development in the small molecule API can be attributed due to the growth observed inโฆ
